Chung, C. H., Zhang, Q., Hammond, E. M., M.Trotti, A., Wang, H., Spencer, S., . . . Ang, K. K. (2010). Integrating EGFR Assay with Clinical Parameters Improves Risk Classification for Relapse and Survival in Head and Neck Squamous Cell Carcinoma.
Παραπομπή Chicago StyleChung, Christine H., et al. Integrating EGFR Assay With Clinical Parameters Improves Risk Classification for Relapse and Survival in Head and Neck Squamous Cell Carcinoma. 2010.
Παραπομπή MLAChung, Christine H., et al. Integrating EGFR Assay With Clinical Parameters Improves Risk Classification for Relapse and Survival in Head and Neck Squamous Cell Carcinoma. 2010.
Πρόσοχή: Οι παραπομπές μπορεί να μην είναι 100% ακριβείς.